Paeoniflorin Alleviates Coronary Artery Lesions in Kawasaki Disease by Activating NRF2 Pathway and Inhibiting CYP2E1 Expression.

Saved in:
Bibliographic Details
Title: Paeoniflorin Alleviates Coronary Artery Lesions in Kawasaki Disease by Activating NRF2 Pathway and Inhibiting CYP2E1 Expression.
Authors: Pan H; Department of Pediatrics, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, No.453, Tiyuchang Road, Xihu District, Zhejiang, Hangzhou, 310007, China. panxiaozhi1214@163.com., Zhang H; Department of Pediatrics, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, No.453, Tiyuchang Road, Xihu District, Zhejiang, Hangzhou, 310007, China., Wang Y; Department of Pediatrics, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, No.453, Tiyuchang Road, Xihu District, Zhejiang, Hangzhou, 310007, China., Wang H; Department of Pediatrics, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, No.453, Tiyuchang Road, Xihu District, Zhejiang, Hangzhou, 310007, China.
Source: Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2026 Jun; Vol. 40 (3), pp. 897-910. Date of Electronic Publication: 2025 Nov 20.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Kluwer Academic For The International Society For Cardiovascular Pharmacotherapy Country of Publication: United States NLM ID: 8712220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7241 (Electronic) Linking ISSN: 09203206 NLM ISO Abbreviation: Cardiovasc Drugs Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1573-7241
DOI:10.1007/s10557-025-07817-8